LensGen
Company

Last deal

$10M

Amount

Venture - Series Unknown

Stage

20.08.2020

Date

9

all rounds

$52M

Total amount

General

About Company
LensGen has developed an intraocular lens that treats cataracts and presbyopia.

Industry

Sector :

Subsector :

founded date

01.08.2011

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The company's Juvene™ lens is designed to fit inside the eye and adjust dioptric power through curvature change using the eye's tiny muscle contractions, allowing patients to restore clear vision at all distances. Presbyopia, the loss of accommodation that occurs with age, is caused by the eye's natural lens becoming less elastic. Juvene™ addresses this issue by changing shape and adjusting focus, providing a permanent solution to eyesight problems caused by cataracts and presbyopia.
Contacts

Social url